Provided by Tiger Trade Technology Pte. Ltd.

ALTSHARES MERGER ARBITRAGE ETF

30.02
+0.67002.28%
Post-market: 30.020.00000.00%19:30 EDT
Volume:28.04K
Turnover:842.20K
Market Cap:103.38M
PE:- -
High:30.07
Open:30.01
Low:30.01
Close:29.35
52wk High:32.48
52wk Low:28.30
Shares:3.44M
Float Shares:3.44M
Volume Ratio:0.49
T/O Rate:0.81%
Dividend:0.13
Dividend Rate:0.42%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

GlobeNewswire
·
Yesterday

ARB Corporation Issues 7,013 New Ordinary Shares After Option Conversions

TIPRANKS
·
Yesterday

Paramount Skydance Corp (PSKY.US) $110 Billion M&A Financing Arrives Late: Bond Issuance Delayed Three Months, May Cost $500 Million More in Annual Interest

Stock News
·
Sep 30

SEC Approves On-Chain Trading of Tokenized US Stocks: Which Platform Tokens Stand to Gain?

TradingKey
·
Sep 26

XRP Reclaims Massive $100 Billion Market Cap

utoday
·
Sep 23

ARB Lifts CEO's Fixed Remuneration

MT Newswires Live
·
Sep 18

ARB Corporation Modestly Lifts CEO Fixed Remuneration

TIPRANKS
·
Sep 18

ArborGen Cancels 464,002 RSUs After Brazil Operations Chief Resigns

TIPRANKS
·
Sep 16

ArborGen Cancels Brazil Executive LTI Shares After Departure

TIPRANKS
·
Sep 16

Arbitrum price jumps 8.8% as $0.155 test looms

cryptonews
·
Sep 16

7,000% Growth by 2030: Standard Chartered Predicts Arbitrum (ARB) to Hit $10

utoday
·
Sep 15

ArborGen Shareholders Back Auditor Mandate and Board Re-Elections

TIPRANKS
·
Sep 15

Arborgen Holdings Limited - Results of Arborgen Holdings Limited’s ASM

THOMSON REUTERS
·
Sep 15

ArborGen Shifts From Expansion to Cash Generation as CEO Exits and Shareholders Press for Value

TIPRANKS
·
Sep 15

ARB Sets October Date for AGM, Board Elections and Proxy Voting

TIPRANKS
·
Sep 11

ARB Corporation Announces Board Changes and Succession Planning Move

TIPRANKS
·
Sep 11

ETF Market Alert: Southern 2x Long NVIDIA ETF (07788) Slides Over 3% Amid Antitrust Probe into NVIDIA-Groq Licensing Deal

Stock News
·
Sep 10

Arbitrum watchdog seeks permanent ban for three grant abuse cases

cryptonews
·
Sep 10

Fox-Roku merger faces extended U.S. antitrust review

TIPRANKS
·
Sep 09

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

GlobeNewswire
·
Sep 09